Bromocriptine –
**Core Concept**
Bromocriptine is a dopamine D2 receptor agonist used in the management of hyperprolactinemia, Parkinson's disease, and acromegaly. It works by stimulating dopamine receptors in the pituitary gland, which leads to a decrease in prolactin secretion and an increase in the release of growth hormone-inhibiting hormone.
**Why the Correct Answer is Right**
Bromocriptine binds to dopamine D2 receptors in the pituitary gland, specifically in the lactotroph cells, which are responsible for the production of prolactin. This agonist activity inhibits the release of prolactin, leading to a decrease in its levels in the blood. In patients with acromegaly, bromocriptine stimulates the release of growth hormone-inhibiting hormone, which in turn decreases the production of growth hormone, thereby reducing insulin-like growth factor-1 (IGF-1) levels.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is not relevant to the mechanism of action of bromocriptine.
**Option B:** Bromocriptine does not have a significant effect on the sympathetic nervous system.
**Option C:** This option is not a known effect of bromocriptine.
**Clinical Pearl / High-Yield Fact**
Bromocriptine is a first-line treatment for hyperprolactinemia, especially in patients with prolactinomas, and is often used in combination with cabergoline to reduce prolactin levels.
**Correct Answer: D.**